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ythium insidiosum infections: Clinical presentations and treat-
ent
. Sathapatayavongs
Mahidol University, Bangkok, Thailand
Pythium insidiosum causes infection in human, various presen-
ations were described namely cutaneous/subcutaneous, arteritis,
nd ocular form. In the most devastating vascular form, patients
resented with symptoms and signs of arterial insufﬁciency: inter-
ittent claudication, pain, chronic ulcers, and leg gangrene. There
ay be prior history of soft tissue infectionwhich ranged from self-
imited to necrotizing one. Natural history of this arteritis is the
scending invasion of the organisms along the arterial wall causing
ntense inﬂammation, destruction of vessel wall, thrombus forma-
ion, aneurysmal dilatation and fatal bleeding from aortic rupture.
urﬁrst recognized casehasdemonstratedall these features, lasted
7months. The reported casesof brain abscesswith internal carotid
rteritis, and gut perforationmay reﬂect the different route of entry
f the organisms. Almost all patients affected have a common pre-
isposing factor, i.e. thalassemia/hemoglobinopathy syndrome. In
ontrast, corneal ulcer caused by Pythium insidiosum occurs in nor-
al hosts mostly. Farmers who work in the tropical area, exposing
o the common habitat of this organisms, are at risk of this infec-
ion. Twenty-ﬁve years have passed but we still know very little
bout Pythium insidiosum. How the chronic hemolysis predisposes
ost with this organism is still an enigma. With the better diagnos-
icmethod, wemay ﬁndmore spectrum of infectionswhich give us
lues to its pathogenesis. Regarding treatment, amphotericinB and
zole agents have been tried but unsuccessfully in our patients.
owever, combination of itraconazole and terbinaﬁne seems to
ork in our few cases. Immunotherapy with Pythium insidiosum
accine (PIV) has been used to treat animals successfully by Dr.
endoza et al. With his vaccine, we have treated our human cases
ith arteritis with 50% success . Surgery remains the mainstay of
reatment, i.e. surgical debridement in case of soft tissue infection,
eratectomy or enucleation in case of ocular infection, and limb
mputation with total removal of infected artery in case of arteri-
is of the limb vessels. Better therapeutic regimen remains to be
iscovered.
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Penicillium marneffei infections
K. Supparatpinyo
Chiang Mai University, Bangkok, Thailand
Penicillium marneffei infection is a systemic fungal infection that
causes morbidity and mortality in immunosuppressed patients
resident in or having visited Southeast Asia, northeastern India,
southern China, Hong Kong and Taiwan.
This systemic fungal infection was commonly diagnosed prior
to the era of potent antiretroviral therapy (ART). The widespread
use of ART has led to a signiﬁcant decline of opportunistic infec-
tions (OIs), including P. marneffei infection in the highly endemic
areas. However, despite the wide availability of ART in Thailand,
P. marneffei infection continues to cause considerable morbidity
and mortality in AIDS patients who are either unaware of their HIV
infection, who do not have access to ART, or who have suboptimal
responses to HIV therapy.
Humans and bamboo rats are the only known animal hosts.
Although the geographic habitats of these bamboo rats correspond
with the regional areaswhere human cases of P. marneffei infection
have been found, deﬁnite proof of an environmental reservoir for
P. marneffei, within the soil or other substrates, is still lacking.
P. marneffei infection usually occurs late in the course of HIV
infection. The majority of cases are observed in patients who have
a CD4+ cell count of <100 cells/mm3. Papular skin lesions provide
a clue for diagnosis. Other clinical manifestations are less speciﬁc,
i.e., fever, weight loss, nonproductive cough, hepatosplenomegaly
and generalized lymphadenopathy.
Diagnosis is made by isolation of the fungus from clinical speci-
mens or identiﬁ cation of organisms in tissue sections. Presumptive
diagnosis can be quicklymade throughmicroscopic examination of
Wright-stained samples of skin scrapings, bonemarrowaspirate, or
lymph node biopsy specimens. The organism can also be identiﬁed
on blood smears of patients with heavy fungemia.
Mortality is high in delayed or untreated patients. Antifungal
therapy with amphotericin B and itraconazole is effective in mostessary; treatment can be discontinued if immune recovery occurs.
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